Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Chieh-yu Peng"'
Autor:
Han-Li Huang, Hsueh-Yun Lee, An-Chi Tsai, Chieh-Yu Peng, Mei-Jung Lai, Jing-Chi Wang, Shiow-Lin Pan, Che-Ming Teng, Jing-Ping Liou
Publikováno v:
PLoS ONE, Vol 7, Iss 9 (2012)
Externí odkaz:
https://doaj.org/article/89e0be62cfe9434f9bb6081c224f99d9
Autor:
Han-Li Huang, Hsueh-Yun Lee, An-Chi Tsai, Chieh-Yu Peng, Mei-Jung Lai, Jing-Chi Wang, Shiow-Lin Pan, Che-Ming Teng, Jing-Ping Liou
Publikováno v:
PLoS ONE, Vol 7, Iss 8, p e43645 (2012)
Recently, histone deacetylase (HDAC) inhibitors have emerged as a promising class of drugs for treatment of cancers, especially subcutaneous T-cell lymphoma. In this study, we demonstrated that MPT0E028, a novel N-hydroxyacrylamide-derived HDAC inhib
Externí odkaz:
https://doaj.org/article/752837e380b74f15ae4149fdd9fbd3f0
Autor:
Chih-Ya Wang, An-Chi Tsai, Chieh-Yu Peng, Ya-Ling Chang, Kuo-Hsiung Lee, Che-Ming Teng, Shiow-Lin Pan
Publikováno v:
PLoS ONE, Vol 7, Iss 2, p e31195 (2012)
The traditional Chinese medicine component dehydrocostuslactone (DHC) isolated from Saussurea costus (Falc.) Lipschitz, has been shown to have anti-cancer activity. Angiogenesis is an essential process in the growth and progression of cancer. In this
Externí odkaz:
https://doaj.org/article/81fb43a7e7654288a2f202d5341bb626
Autor:
Chieh-Yu Peng, 彭婕妤
96
Arterial reconstruction procedures, including balloon angioplasty, stenting and coronary artery bypass, are used to restore blood flow in atherosclerotic arteries. Restenosis of these arteries is a major limitation of the application of these
Arterial reconstruction procedures, including balloon angioplasty, stenting and coronary artery bypass, are used to restore blood flow in atherosclerotic arteries. Restenosis of these arteries is a major limitation of the application of these
Externí odkaz:
http://ndltd.ncl.edu.tw/handle/89451110702908227657
Autor:
Chieh-yu Peng, 彭婕妤
95
The purpose of this paper is to investigate a simple portfolio problem with one risky asset and one risk-free asset: how we choose the weight on the risky asset in order to maximize the expected utility.We consider an investor who rebalances
The purpose of this paper is to investigate a simple portfolio problem with one risky asset and one risk-free asset: how we choose the weight on the risky asset in order to maximize the expected utility.We consider an investor who rebalances
Externí odkaz:
http://ndltd.ncl.edu.tw/handle/50475413629602228807
Investigation of YD-3-mediated inhibition on carotid artery restenosis after balloon injury in rats.
Autor:
Chieh-Yu Peng, 彭婕妤
90
Proliferation of vascular smooth muscle cells (VSMCs) is postulated to be one of the key events in the pathogenesis of atherosclerosis. Previous study suggests that YD-3, a synthetic indazole derivative, inhibits the aggregation of platel
Proliferation of vascular smooth muscle cells (VSMCs) is postulated to be one of the key events in the pathogenesis of atherosclerosis. Previous study suggests that YD-3, a synthetic indazole derivative, inhibits the aggregation of platel
Externí odkaz:
http://ndltd.ncl.edu.tw/handle/88361351219091415432
Autor:
Yang Chang Wu, Bang Jau You, Fei Ching Chang, Te-Ling Lu, Chia Lin Lee, Chieh Yu Peng, Hong-Zin Lee, Wen-Hsin Lin
Publikováno v:
The American Journal of Chinese Medicine. 44:617-636
4[Formula: see text]-Hydroxywithanolide E is an active component of the extract of Physalis peruviana that has been reported to exhibit antitumor effects. Although the involvement of reactive oxygen species (ROS) production and the ataxia-telangiecta
Autor:
Yang Chang Wu, Dayong Zhang, Wen-Jeng Wu, Juan-Cheng Yang, Fang Rong Chang, Wei Yu Hsu, Ching Chia Li, Chia Lin Lee, Yun Hao Dai, Chieh Yu Peng, Mei-Chin Lu
Publikováno v:
Oncotarget
DNA damage responses contribute to cisplatin resistance; however, therapeutic strategies to overcome cisplatin resistance have not yet been established. Here, we demonstrate that inhibition of ATR-Chk1 pathway with the potent inhibitor WYC0209 sensit
Autor:
Chao Feng Lin, Chieh Yu Peng, Yu Ching Lee, Hui-Po Wang, Han Li Huang, Che-Ming Teng, Shiow Lin Pan
Publikováno v:
Toxicology and Applied Pharmacology. 387:114858
Autor:
Benjamin Daniel, Zhifei Liu, Stephen Midgley, Adam Klaus, Zhen Sun, Chieh-Yu Peng, Rui Wang, Xiao-Long Huang, Chih-Chieh Su, Robert Aduddell, Edwin Garrett, Michael J. Dorais, Yang Zhang, Chad Broyles, Sam McLelland, Steven Thomas, Joann M. Stock, Jacopo Boaga, Ty Cobb, Jessica L. Hinojosa, Akira Furusawa, Roy Davis, Rong Xiang, Alyssa Stephens, T. W. Höfig, Steven M. Skinner, Erik Moortgat, Caroline Robinson, Anders McCarthy, Zenon Mateo, Xiang Su, Antonio Luna, Anne Briais, Chao Lei, Yifeng Chen, Michael Nirrengarten, Kan Hsi Hsiung, Vincent Percuoco, Rajeev Yadav, Kerry Swain, Liang Yi, William Crawford, Jinchang Zhang, Benjamin G. Johnson, Etienne Claassen, Jiansong Zhang, Ning Zhao, Alessia Cicconi, Li Li, Lifeng Zhong, Cuimei Zhang, Isabel Sauermilch, David Fackler, Seth Frank, Rachael Gray, Alexis Armstrong, Jan Jurie Kotze, Claudia Lupi, Terry Skinner, Baoqi Huang, Michael Cannon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6ead66fcceb6d66a866020546a018d1d
https://doi.org/10.14379/iodp.pr.367.2018
https://doi.org/10.14379/iodp.pr.367.2018